Related Experiment Videos
Septic superior ophthalmic vein thrombosis: to coagulate or not to coagulate?
Clinical & Experimental Ophthalmology
|November 13, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ultrasound Surveillance in Melanoma Management: Bridging Diagnostic Promise with Real-World Adherence: A Systematic Review and Meta-Analysis.
American journal of clinical dermatology·2024
Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies.
Arteriosclerosis, thrombosis, and vascular biology·2024
Ultra-short cell-free DNA fragments enhance cancer early detection in a multi-analyte blood test combining mutation, protein and fragmentomics.
Clinical chemistry and laboratory medicine·2023
The incidence of occult level IV nodal metastasis in tongue squamous cell carcinoma: a 20 year review.
ANZ journal of surgery·2022
Tattoo Inflammation With Uveitis: From Recognition to Definition.
Clinical & experimental ophthalmology·2026
VEGF-A Antisense Oligonucleotide Therapy Inhibits Corneal Neovascularisation and Enhances Graft Survival in Murine High-Risk Corneal Transplantation.
Clinical & experimental ophthalmology·2026
Kcnv2 E151X Mouse Captures Hallmarks of KCNV2-Associated Retinal Dystrophy.
Clinical & experimental ophthalmology·2026
Correcting Axial Length-Related Magnification Errors in Optical Coherence Tomography Angiography Improves Machine Learning Classification Performance in High Myopia.
Clinical & experimental ophthalmology·2026
Reactivation of Thyroid Eye Disease: Incidence, Timing and Clinical Phenotype.
Clinical & experimental ophthalmology·2026
Association of Time of Day With Functional Outcome in Intracerebral Hemorrhage.
European journal of neurology·2026
Development of CRISPR_SCD001, an Autologous Hematopoietic Stem Cell Gene Therapy for Sickle Cell Disease after CRISPR-Cas9 Mediated Correction.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
A new player in hemolytic uremic syndrome: the plasma kallikrein-kinin system, a target of heme.
Kidney international·2026